<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font22 { font-size : 22; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font22">and </span>
   <span class="font16">for </span>
   <span class="font12">pharmacovigilance </span>
   <span class="font12">medicinal </span>
   <span class="font12">system </span>
   <span class="font12">safety </span>
   <span class="font12">information </span>
   <span class="font11">The </span>
   <span class="font11">national </span>
   <span class="font11">product </span>
   <span class="font11">may </span>
   <span class="font11">with </span>
   <span class="font11">data </span>
   <span class="font11">global </span>
   <span class="font11">are </span>
   <span class="font11">from </span>
   <span class="font11">{background </span>
   <span class="font11">local </span>
   <span class="font11">not </span>
   <span class="font11">NRAs </span>
   <span class="font11">has </span>
   <span class="font11">should </span>
   <span class="font11">that </span>
   <span class="font11">IPVG </span>
   <span class="font11">this </span>
   <span class="font11">margin </span>
   <span class="font11">regulatory </span>
   <span class="font11">systems </span>
   <span class="font11">{border-style </span>
   <span class="font10">risks </span>
   <span class="font10">use </span>
   <span class="font10">Accessed </span>
   <span class="font10">Jan </span>
   <span class="font10">any </span>
   <span class="font10">px;} </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">NRA </span>
   <span class="font10">available </span>
   <span class="font10">where </span>
   <span class="font10">additional </span>
   <span class="font10">also </span>
   <span class="font10">have </span>
   <span class="font10">MAH </span>
   <span class="font10">such </span>
   <span class="font10">[]. </span>
   <span class="font10">marketing </span>
   <span class="font10">public </span>
   <span class="font10">their </span>
   <span class="font10">(see </span>
   <span class="font10">International </span>
   <span class="font10">authorisation </span>
   <span class="font10">effective </span>
   <span class="font10">employed </span>
   <span class="font10">other </span>
   <span class="font10">reporting </span>
   <span class="font10">which </span>
   <span class="font10">MAHs </span>
   <span class="font10">adverse </span>
   <span class="font10">inspection </span>
   <span class="font10">new </span>
   <span class="font10">recommends </span>
   <span class="font10">signal </span>
   <span class="font10">[], </span>
   <span class="font10">activities </span>
   <span class="font10">benefitâ€"risk </span>
   <span class="font10">but </span>
   <span class="font10">countries </span>
   <span class="font10">country </span>
   <span class="font10">interest. </span>
   <span class="font10">reported </span>
   <span class="font10">when </span>
   <span class="font10">For </span>
   <span class="font10">Module </span>
   <span class="font10">Pharmacovigilance </span>
   <span class="font10">conflicts </span>
   <span class="font10">drug </span>
   <span class="font10">i.e. </span>
   <span class="font10">requirements </span>
   <span class="font10">risk-minimisation </span>
   <span class="font10">well </span>
   <span class="font10">(GVP) </span>
   <span class="font10">European </span>
   <span class="font10">ICSRs </span>
   <span class="font10">Medicines </span>
   <span class="font10">all </span>
   <span class="font10">article </span>
   <span class="font10">can </span>
   <span class="font10">description </span>
   <span class="font10">detection </span>
   <span class="font10">guidance </span>
   <span class="font10">required </span>
   <span class="font10">risk </span>
   <span class="font10">submission </span>
   <span class="font10">support </span>
   <span class="font10">used </span>
   <span class="font10">.European </span>
   <span class="font10">Agency. </span>
   <span class="font10">EMA. </span>
   <span class="font10">Guideline </span>
   <span class="font10">MAHâ€™s </span>
   <span class="font10">Safety </span>
   <span class="font10">Table </span>
   <span class="font10">addition, </span>
   <span class="font10">document </span>
   <span class="font10">good </span>
   <span class="font10">management </span>
   <span class="font10">need </span>
   <span class="font10">practices </span>
   <span class="font10">px; </span>
   <span class="font10">situations </span>
   <span class="font10">using </span>
   <span class="font10">{font-family </span>
   <span class="font10">(Rev.). </span>
   <span class="font10">ICSR </span>
   <span class="font10">Management </span>
   <span class="font10">PBRER </span>
   <span class="font10">Sect.Â </span>
   <span class="font10">Signal </span>
   <span class="font10">This </span>
   <span class="font10">communication </span>
   <span class="font10">contact </span>
   <span class="font10">development </span>
   <span class="font10">font-size </span>
   <span class="font10">include </span>
   <span class="font10">person </span>
   <span class="font10">potential </span>
   <span class="font10">products </span>
   <span class="font10">profile </span>
   <span class="font10">provide </span>
   <span class="font10">relevant </span>
   <span class="font10">report </span>
   <span class="font10">reports </span>
   <span class="font10">review </span>
   <span class="font10">signals </span>
   <span class="font10">specific </span>
   <span class="font10">ADRs </span>
   <span class="font10">EU-RMP </span>
   <span class="font10">Electronic </span>
   <span class="font10">Health </span>
   <span class="font10">ICH </span>
   <span class="font10">Periodic </span>
   <span class="font10">RMP </span>
   <span class="font10">Requirements </span>
   <span class="font10">WHO </span>
   <span class="font10">access </span>
   <span class="font10">active </span>
   <span class="font10">and/or </span>
   <span class="font10">authorised </span>
   <span class="font10">between </span>
   <span class="font10">days </span>
   <span class="font10">does </span>
   <span class="font10">double; </span>
   <span class="font10">e.g. </span>
   <span class="font10">expedited </span>
   <span class="font10">experience </span>
   <span class="font10">exposure </span>
   <span class="font10">format </span>
   <span class="font10">individual </span>
   <span class="font10">key </span>
   <span class="font10">legislation </span>
   <span class="font10">level </span>
   <span class="font10">maintain </span>
   <span class="font10">only </span>
   <span class="font10">periodic </span>
   <span class="font10">planning </span>
   <span class="font10">providing </span>
   <span class="font10">recommendations </span>
   <span class="font10">relationship </span>
   <span class="font10">serious </span>
   <span class="font10">service </span>
   <span class="font10">significant </span>
   <span class="font10">special </span>
   <span class="font10">standards </span>
   <span class="font10">via </span>
   <span class="font10">(e.g. </span>
   <span class="font10">Council </span>
   <span class="font10">Drug </span>
   <span class="font10">Global </span>
   <span class="font10">HCPs </span>
   <span class="font10">LSR </span>
   <span class="font10">Pharmaceutical </span>
   <span class="font10">Report </span>
   <span class="font10">Supplementary </span>
   <span class="font10">VigiFlow </span>
   <span class="font10">VigiLyze </span>
   <span class="font10">according </span>
   <span class="font10">action </span>
   <span class="font10">activity </span>
   <span class="font10">applicable </span>
   <span class="font10">been </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">case </span>
   <span class="font10">collection </span>
   <span class="font10">considered </span>
   <span class="font10">consistent </span>
   <span class="font10">criteria </span>
   <span class="font10">current </span>
   <span class="font10">described </span>
   <span class="font10">direct </span>
   <span class="font10">during </span>
   <span class="font10">framework </span>
   <span class="font10">further </span>
   <span class="font10">health </span>
   <span class="font10">into </span>
   <span class="font10">material </span>
   <span class="font10">most </span>
   <span class="font10">must </span>
   <span class="font10">necessarily </span>
   <span class="font10">own </span>
   <span class="font10">per </span>
   <span class="font10">regional </span>
   <span class="font10">regulators </span>
   <span class="font10">resources </span>
   <span class="font10">sharing </span>
   <span class="font10">solid; </span>
   <span class="font10">some </span>
   <span class="font10">suspected </span>
   <span class="font10">system. </span>
   <span class="font10">systems. </span>
   <span class="font10">those </span>
   <span class="font10">time </span>
   <span class="font10">understanding </span>
   <span class="font10">will </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">ADR </span>
   <span class="font10">Arab </span>
   <span class="font10">CIOMS </span>
   <span class="font10">Commons </span>
   <span class="font10">Creative </span>
   <span class="font10">EU-GVP </span>
   <span class="font10">Harmonisation </span>
   <span class="font10">ICSRs, </span>
   <span class="font10">NRA. </span>
   <span class="font10">Not </span>
   <span class="font10">Organization. </span>
   <span class="font10">PSMF </span>
   <span class="font10">Person </span>
   <span class="font10">RMPs </span>
   <span class="font10">Risk </span>
   <span class="font10">Tanja </span>
   <span class="font10">Use </span>
   <span class="font10">activities. </span>
   <span class="font10">aligned </span>
   <span class="font10">allow </span>
   <span class="font10">applicable, </span>
   <span class="font10">assessment </span>
   <span class="font10">authors </span>
   <span class="font10">avoid </span>
   <span class="font10">based </span>
   <span class="font10">bold </span>
   <span class="font10">calendar </span>
   <span class="font10">clinical </span>
   <span class="font10">containing </span>
   <span class="font10">country, </span>
   <span class="font10">country-specific </span>
   <span class="font10">courier; </span>
   <span class="font10">database </span>
   <span class="font10">efficacy </span>
   <span class="font10">elements </span>
   <span class="font10">em; </span>
   <span class="font10">emerging </span>
   <span class="font10">established </span>
   <span class="font10">evaluation </span>
   <span class="font10">event </span>
   <span class="font10">example, </span>
   <span class="font10">existing </span>
   <span class="font10">extensive </span>
   <span class="font10">glossary </span>
   <span class="font10">included </span>
   <span class="font10">known </span>
   <span class="font10">legal </span>
   <span class="font10">level. </span>
   <span class="font10">measures </span>
   <span class="font10">multiple </span>
   <span class="font10">needs </span>
   <span class="font10">online </span>
   <span class="font10">operating </span>
   <span class="font10">order </span>
   <span class="font10">patient </span>
   <span class="font10">patients </span>
   <span class="font10">patients. </span>
   <span class="font10">performance </span>
   <span class="font10">pharmaceutical </span>
   <span class="font10">place </span>
   <span class="font10">productâ€™s </span>
   <span class="font10">provides </span>
   <span class="font10">pt;} </span>
   <span class="font10">reference </span>
   <span class="font10">regions </span>
   <span class="font10">require </span>
   <span class="font10">requires </span>
   <span class="font10">single </span>
   <span class="font10">stakeholders, </span>
   <span class="font10">structure </span>
   <span class="font10">supplementary </span>
   <span class="font10">supports </span>
   <span class="font10">system, </span>
   <span class="font10">technical </span>
   <span class="font10">there </span>
   <span class="font10">training </span>
   <span class="font10">translation </span>
   <span class="font10">update </span>
   <span class="font10">was </span>
   <span class="font10">without </span>
   <span class="font10">working </span>
  </p>
 </body>
</html>
